Figure 9. Treatment with a water-based gel containing the EG complex at 3.0% and 1.0% reduced SLS-induced TEWL on human volunteers (n = 25); * = statistically significant.

At 120 min of application, the 3.0% EG complex gel reduced TEWL by 23% (see Figure 9).